Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older, of any gender
- People who have been diagnosed with postherpetic neuralgia (long-lasting nerve pain after shingles) by a qualified doctor, and for whom peripheral nerve stimulation therapy has been recommended
- People whose nerve-related pain has been assessed before the procedure using a specific four-question pain screening tool called the Douleur Neuropathy questionnaire
- People who have already tried standard treatments but found them ineffective, or who were unable to tolerate the side effects of those treatments
- People whose pain score on a standard 0–10 pain scale was 5 or higher in the 24 hours before the procedure
- People who are able to understand the purpose of the study, are willing to follow the study requirements, and are willing to sign a consent form
Who may not be able to join:
- People who also need to receive both radiofrequency nerve treatment and a drug-delivery pump implant at the same time
- People who already have a heart device implanted (such as a pacemaker or defibrillator) or another implanted nerve stimulation device (such as a spinal cord or deep brain stimulator)
- People with serious psychological or psychiatric conditions, or dependence on non-prescribed drugs
- People expected to need an MRI scan within 30 days of having the nerve stimulator implanted
- People expected to leave hospital within 48 hours or less
- People with known damage to the target nerve or muscle loss in the painful area
- People known to be allergic to skin contact materials such as tape or adhesive
- People with a known allergy to anaesthetic medicines such as lidocaine
- People with serious heart, liver, kidney, or respiratory (breathing) conditions, or blood clotting problems
- Women who are pregnant, breastfeeding, or planning to become pregnant within the next three months
- People who are currently taking part in another clinical trial, or who may join another trial after enrolling in this one
- People the research team considers unsuitable for the trial for other reasons (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13871230491
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference in mean pain visual analogue scale VAS scores between trial and control groups in the randomised withdrawal period; Visual simulation assessment scale collects pain scores after peripheral electrode placement
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.